Acute Lymphocytic/Lymphoblastic Leukemia Market: 4% CAGR Forecast to 2019, Company Profiles and More

Nov 20, 2015, 05:00 ET from Sandler Research

PUNE, India, November 20, 2015 /PRNewswire/ --

Several factors are driving global acute lymphocytic leukemia therapeutics market growth including presence of high unmet needs for appropriate drugs while current treatment options cannot cure the disease completely and hence the demand remains high. Therefore, drugs that can cause disease remission in patients are expected to drive the growth of the market.

Complete report on acute lymphocytic / lymphoblastic leukemia market spread across 65 pages, analyzing 3 major companies and providing 20 data exhibits is now available at

The rise in awareness programs to treat acute lymphocytic leukemia patients is one such trend. It increases the treatment-seeking rate among patients, which results in an increase in overall consumption of medicines. The market research analysts expect the global acute lymphocytic leukemia market to grow at a steady rate and post a CAGR of over 4% during the forecast period. One of the major factors contributing to the growth of the market is the provision for orphan drugs. For instance, in the US, orphan designation for a drug means incentives like tax credits for qualified clinical testing, exemption from prescription drug user fees unless indicated for additional non-orphan indications and market exclusivity for seven years.

The acute lymphocytic leukemia market is segmented by route of administration: Oral and Parenteral. Many medications are administered through the oral route to guarantee a systemic effect. The oral route is a sub-division of enteral administration and is considered to be one of the safest and most preferred routes of drug administration.

Geographical segmentation of the acute lymphocytic leukemia market: With a share of over 49%, the Americas dominated the industry, with US being the major revenue contributor. The Americas is closely followed by the EMEA and the APAC region and the market is expected to follow a similar trend during the forecast period. Order a copy of Global Acute Lymphocytic / Lymphoblastic leukemia Market 2015 - 2019 report @

The market is marked by the presence of both global and local drug manufacturers with varied product portfolios containing generic and off- label drugs as well as branded therapies. Besides, the high level of unmet medical need is expected to give a platform to the vendors to develop products to cater to relevant areas and enhance their market shares. The key players in the global acute lymphocytic leukemia market are Amgen, Bristol-Myers Squibb and Novartis. And other prominent vendors in the market are Ariad, Arno Therapeutics, Baxter, Boehringer Ingelheim, ERYTECH Pharma, Fate Therapeutics, Jazz Pharmaceuticals, Orphan Europe, Otsuka, Ono Pharmaceuticals, Onconova Therapeutics, Pfizer, Regeneron Pharmaceuticals, Sanofi, and Sigma-Tau Pharmaceuticals.

Further, the report states that the high cost of treatment is one of the major challenges hindering the growth of the market.

A Related Report, Global Orphan Drugs Market 2015 - 2019 forecasts this orphan drugs industry to grow at a CAGR of 10.05% over the period 2014-2019. The global orphan drugs market is expected to witness certain emerging trends. Increased focus on biologics is one such trend. Biologics are expected to be a preferred treatment option for the medical fraternity, patients, and the families of patients. This in turn will raise the number of treatment-seeking patients, which results in an increase in the overall consumption of medicines. Access the complete report that includes vendor analysis, geographical segmentations, trends, drives and data exhibits at .

Explore more reports on pharmaceuticals market at .

About Us: offers in-depth studies and research reports on a range of micro markets. Not limited to any one industry, offers research studies on agriculture, energy and power, chemicals, environment, pharmaceuticals, biotechnology, water, advanced materials and much more.

Ritesh Tiwari
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
Maharashtra, India.
+ 1 888 391 5441

Connect With Us on: 



G+ / Google Plus:


SOURCE Sandler Research